Key Takeaways
- Seres Automobile Co. has filed a patent for a personalized anti‑motion sickness system that dynamically adjusts recommendations based on real‑time user feedback and vehicle data.
- The technology builds a user‑specific model from active feedback, driving status, and road‑environment information, then updates it continuously to provide precise mitigation suggestions.
- In 2025 Seres reported record revenue of ¥165.05 billion (+13.69 % YoY) and modest profit growth, underscoring resilience amid fierce EV price competition.
- R&D investment surged 77.4 % to ¥12.51 billion, expanding the R&D workforce to 9,019 employees (41.1 % of total staff) and boosting the company’s patent portfolio to 8,046 authorized patents.
- Recent product innovations include Seres Smart Safety, Magic Cube Platform 2.0, and the fifth‑generation 2.0 T Super Range Extender, reflecting a technology‑driven growth strategy.
Seres’ Personalized Anti‑Motion Sickness Patent
Seres Automobile Co. recently disclosed a patent application titled “personalized anti‑motion sickness method, device, equipment, medium, and vehicle,” as recorded by Qichacha and reported by Gasgoo. The abstract outlines an integrated system designed to prevent motion sickness by tailoring interventions to each individual occupant. Rather than applying a one‑size‑fits‑all remedy, the invention captures real‑time physiological and behavioral feedback from users while the vehicle is moving, correlates this feedback with driving status and road‑environment data, and continuously refines a user‑specific anti‑motion sickness model. This model then analyzes live driving data to generate actionable recommendations—such as adjustments to cabin climate, seating position, or driving style—that aim to reduce the likelihood of nausea and discomfort. The core advantage lies in the active feedback loop: by updating the model with each user’s response, the system becomes increasingly accurate and user‑friendly over time.
How the System Works: Data Collection and Model Building
The method begins when a passenger voluntarily triggers a feedback signal—perhaps via a button, voice command, or wearable sensor—indicating the onset or severity of motion sickness symptoms. Simultaneously, the vehicle logs relevant driving parameters (speed, acceleration, braking, steering angle) and extrinsic road data (curvature, surface texture, weather conditions). These multimodal inputs are aggregated into a sample dataset that serves as the foundation for training a personalized predictive model. Machine‑learning techniques are employed to identify patterns linking specific driving motions and environmental factors to the user’s reported discomfort. As more feedback is gathered, the model is iteratively updated, improving its ability to forecast when symptoms are likely to occur and to prescribe pre‑emptive countermeasures.
Real‑Time Recommendation Generation
Once the personalized model is sufficiently trained, it operates in real time during subsequent trips. The system continuously ingests live driving data, runs it through the updated model, and outputs recommendations calibrated to the individual’s susceptibility profile. For example, if the model detects a pattern of increased lateral acceleration on winding roads that historically triggers nausea for a particular user, it might suggest reducing speed, activating a gentle cabin vibration, or adjusting the seat recline to align the vestibular system more closely with visual cues. Because the recommendations are derived from a model that has been honed by that user’s own feedback, they are markedly more precise than generic anti‑motion sickness settings found in many current vehicles.
Benefits: Precision and Ease of Use
Seres emphasizes that the active feedback‑driven refinement process significantly enhances both the precision and usability of anti‑motion sickness features. Traditional systems often rely on universal thresholds or fixed algorithms, which can either over‑correct (leading to unnecessary interventions) or under‑correct (leaving passengers uncomfortable). By contrast, the personalized approach adapts to each occupant’s unique physiological response, reducing false positives and negatives. Moreover, because the user initiates feedback only when needed, the system remains unobtrusive during periods of comfort, preserving a seamless travel experience. The combination of heightened accuracy and minimal user burden positions the technology as a compelling differentiator in the premium EV market.
Financial Performance in 2025
Beyond the technological showcase, Seres’ 2025 financial results reinforce its strategic focus on innovation. The company generated approximately ¥165.05 billion in revenue, marking a 13.69 % year‑over‑year increase and setting a new record. Net profit attributable to shareholders rose modestly by 0.18 % to ¥5.96 billion, representing the second consecutive year of profitability. These figures demonstrate Seres’ ability to maintain growth and earnings stability even as the broader new‑energy vehicle (NEV) sector contends with intense price wars and compressing margins. The steady profit trajectory suggests that the company’s investments in high‑value technology are beginning to translate into tangible market advantages.
R&D Expansion and Patent Portfolio
A cornerstone of Seres’ resilience is its aggressive commitment to research and development. In 2025, R&D spending surged 77.4 % to ¥12.51 billion, outpacing industry averages in both absolute growth and intensity relative to revenue. This investment facilitated a 45.4 % increase in the R&D workforce, bringing the total to 9,019 employees—now constituting 41.1 % of the company’s overall staff. The expanded talent base has yielded a robust intellectual property output: Seres holds 8,046 authorized patents, underscoring its capability to protect and leverage innovative concepts such as the personalized anti‑motion sickness system. The patent surge not only safeguards current inventions but also creates a defensive moat against competitors seeking to replicate similar technologies.
Technological Product Highlights
Seres’ product lineup reflects the fruits of its R&D push. Notable introductions include Seres Smart Safety, an integrated suite of driver‑assistance and passenger‑well‑being features; Magic Cube Platform 2.0, a modular vehicle architecture designed for flexibility across multiple EV models; and the Super Range Extender series, which recently saw the completion of its fifth‑generation 2.0 T iteration. These offerings collectively aim to enhance vehicle efficiency, safety, and user experience. The anti‑motion sickness patent dovetails neatly with the Smart Safety ecosystem, suggesting that future Seres models may embed the personalized wellness system as a standard or optional feature, further differentiating the brand in a crowded market.
Strategic Outlook
Looking ahead, Seres’ emphasis on technology‑driven innovation appears poised to sustain its competitive edge. The personalized anti‑motion sickness system exemplifies how the company leverages user‑centric data analytics to solve real‑world pain points, while its strong financial performance and expanding R&D base provide the resources necessary to bring such ideas to market. As EV manufacturers grapple with pricing pressure and margin strain, Seres’ strategy of coupling high‑value technological advancements with solid fiscal discipline may enable it to capture premium segments, cultivate brand loyalty, and continue delivering growth amid industry turbulence.
All rights reserved. Do not reproduce, copy, or use the editorial content without permission. Contact: [email protected]